R&D Solutions for
Drug Discovery & Development

Realize the potential of data-driven drug discovery and development

Get started

We deliver on-demand scientific data and analytics so you can discover and develop innovative, targeted drugs

Realizing the potential of data-driven drug discovery & development is time and resource intensive. Success requires connecting, combining and using data from disparate sources and enabling the right context for data.

How we help
We are a global leader in scientific data and analytics, offering deep experience in helping pharmaceutical companies extract value from unstructured data to drive successful drug discovery and development.

Pharma & Life Sciences - R&D Solutions | Elsevier

Our pharma & life sciences solutions — Reaxys, ScienceDirect, Scopus, Embase, PharmaPendium and Pathway Studio — are used by chemists, biologists, and other researchers at leading companies to:

  • Sift through disease and -omics data to prioritize targets and progress-relevant molecules and identify patient populations
  • Identify the most promising lead compounds for disease treatment, covering critical areas of medicinal chemistry research

Ready to take the next step?
Contact us

  • Understand the breadth of available research surrounding a disease and identify partnerships for cutting edge research
  • Better integrate external research with in-house data to simplify comparisons and get insights into experimental results

Elsevier's R&D Solutions - Pharma & Life Sciences Solution Finder

Answer a few questions to see which of our pharma & life sciences solutions can help you. From drug discovery to post-market, we offer solutions that can help you drive commercial success and manage risk.
Find the right solutions for your needs

Customer stories

Thousands of researchers and other pharma R&D professionals working in drug discovery and development rely on our solutions.

Customer story - Pharma & Life Sciences - R&D Solutions | Elsevier

How a mid-market biopharma company avoids the risks of being wrong

Limiting early-stage research to only abstracts and excerpts increases the risk that essential information is overlooked, which can result in substantial costs later on. Find out how a pre-clinical research leader avoids these risks by using ScienceDirect.

Read the customer story

Designing therapeutics that treat disease by restoring normal circadian clock function

Reset Therapeutics is a discovery-stage biopharma company developing first-in-class approaches to treating diseases by restoring the body’s natural 24-hour, or circadian, rhythms. As a participant of Elsevier's Hive project, they use Reaxys to drive their work forward.

Watch the video to learn how

Elsevier's R&D Solutions for Drug Discovery & Development


Drive successful early drug discovery by providing chemists the shortest path to relevant literature, patent information, valid compound properties, and experimental procedures.

Learn more about Reaxys

Reaxys Medicinal Chemistry

Achieve more efficient hit identification and lead optimization by providing chemists the shortest path to normalized compound–target affinity data and comprehensive pharmacokinetic, efficacy, toxicity, safety and metabolic profiles.
Learn more about Reaxys Medicinal Chemistry


Uncover drug-disease relationships and drug-drug interactions by increasing the discovery of biomedical evidence and providing comprehensive relevant, up-to-date biomedical information.

Learn more about Embase


Make more informed drug development decisions on safety and efficacy, risk assessments and mitigation, and study designs by providing researchers with searchable FDA/EMA drug approval documents and comparative drug safety data.
Learn more about PharmaPendium

Professional Services

Drive innovative pharmaceutical research by resolving challenges with data quality and integration and making data easier for researchers to compare, analyze, interpret and share.

Learn more about Professional Services

Pathway Studio

Streamline target and biomarker identification and drug repurposing by providing biological researchers with greater insight into the mechanisms of disease and facilitating the interpretation of experimental data.
Learn more about Pathway Studio


Help researchers understand the entire breadth of research surrounding a disease by helping them more effectively and efficiently search authoritative, full-text scientific, technical and health content.

Learn more about ScienceDirect


Detect trends, find partnerships and identify experts to stay on the cutting edge of research through the world’s largest abstract and citation database of peer-reviewed literature, including tools to track, analyze and visualize research.
Learn more about Scopus

Text Mining

Help pharmaceutical R&D professionals and other researchers get meaningful answers to complex pharmaceutical research questions through rapid retrieval of highly specified information from unstructured content.
Learn more about Text Mining

Ideas and insights for industry professionals

Real Stories. Real Science. Real Time.

Real Stories. Real Science. Real Time. - R&D Solutions | Elsevier

Visit the Hive to explore how biotech and pharma start-ups are using Elsevier R&D solutions to solve for early-stage drug discovery and development.

Learn more about the Hive

Precision Medicine in R&D

Precision Medicine in R&D - R&D Solutions | Elsevier

Drug makers are turning their focus from developing blockbuster drugs to making advances in precision medicine treatments. But what will they need to do to succeed?

Read the white paper

The Era of Immunotherapeutics

The Era of Immunotherapeutics - R&D Solutions | Elsevier

By boosting anti-cancer response using a patient’s own immune system, immunotherapeutics are showing incredible promise in offering more effective treatments with fewer side effects for cancer patients.

Read the white paper